Unum Group (NYSE:UNM – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the nine research firms that are covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $61.44.
Several research firms recently commented on UNM. Truist Financial raised their target price on Unum Group from $62.00 to $70.00 and gave the company a “buy” rating in a research report on Thursday, August 1st. Citigroup lifted their price objective on shares of Unum Group from $62.00 to $69.00 and gave the company a “buy” rating in a research note on Tuesday, July 23rd. JPMorgan Chase & Co. increased their target price on shares of Unum Group from $64.00 to $65.00 and gave the company an “overweight” rating in a research report on Wednesday, July 31st. Morgan Stanley boosted their price target on shares of Unum Group from $50.00 to $52.00 and gave the stock an “equal weight” rating in a research report on Monday, April 15th. Finally, Piper Sandler started coverage on shares of Unum Group in a report on Thursday, July 11th. They issued an “overweight” rating and a $57.00 price objective for the company.
Read Our Latest Research Report on UNM
Institutional Investors Weigh In On Unum Group
Unum Group Stock Performance
Shares of UNM traded up $0.54 during midday trading on Friday, hitting $53.63. 781,286 shares of the stock traded hands, compared to its average volume of 1,266,470. The business’s 50 day moving average price is $52.00 and its two-hundred day moving average price is $51.28. The firm has a market capitalization of $9.96 billion, a PE ratio of 7.97, a price-to-earnings-growth ratio of 0.78 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.28 and a current ratio of 0.28. Unum Group has a 1-year low of $41.75 and a 1-year high of $58.17.
Unum Group (NYSE:UNM – Get Free Report) last posted its earnings results on Tuesday, July 30th. The financial services provider reported $2.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.02 by $0.14. Unum Group had a net margin of 10.40% and a return on equity of 15.55%. The firm had revenue of $3.23 billion during the quarter, compared to analyst estimates of $3.23 billion. During the same period in the previous year, the business posted $2.06 EPS. Unum Group’s revenue was up 3.9% on a year-over-year basis. Equities research analysts predict that Unum Group will post 8.52 EPS for the current fiscal year.
Unum Group Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, August 16th. Shareholders of record on Friday, July 26th will be given a $0.42 dividend. This is a positive change from Unum Group’s previous quarterly dividend of $0.37. The ex-dividend date of this dividend is Friday, July 26th. This represents a $1.68 annualized dividend and a yield of 3.13%. Unum Group’s payout ratio is 24.96%.
Unum Group announced that its Board of Directors has approved a share repurchase plan on Tuesday, July 30th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the financial services provider to reacquire up to 10% of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board believes its shares are undervalued.
Unum Group Company Profile
Unum Group, together with its subsidiaries, provides financial protection benefit solutions primarily in the United States, the United Kingdom, Poland, and internationally. It operates through Unum US, Unum International, Colonial Life, and Closed Block segment. The company offers group long-term and short-term disability, group life, and accidental death and dismemberment products; supplemental and voluntary products, such as individual disability, voluntary benefits, and dental and vision products; and accident, sickness, disability, life, and cancer and critical illness products.
Featured Articles
- Five stocks we like better than Unum Group
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- MarketBeat Week in Review – 8/5 – 8/9
- How to invest in marijuana stocks in 7 steps
- Cassava Sciences: A Hot Stock to Trade, Invest, or Avoid?
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- The Cannabis Sector: Profitability Takes Center Stage
Receive News & Ratings for Unum Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unum Group and related companies with MarketBeat.com's FREE daily email newsletter.